会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 11. 发明申请
    • MONITORING HEALTH AND DISEASE STATUS USING CLONOTYPE PROFILES
    • 使用CLONOTYPE配置文件监测健康和疾病状态
    • US20150065352A1
    • 2015-03-05
    • US14176551
    • 2014-02-10
    • Malek FahamThomas Willis
    • Malek FahamThomas Willis
    • C12Q1/68
    • C12Q1/6886C12Q1/6874C12Q1/6881C12Q1/6883C12Q2600/112C12Q2600/118C12Q2600/156C12Q2600/158C12Q2600/16
    • There is a need for improved methods for determining the diagnosis and prognosis of patients with conditions, including autoimmune disease and cancer, especially lymphoid neoplasms, such as lymphomas and leukemias. Provided herein are methods for using DNA sequencing to identify personalized, or patient-specific biomarkers in patients with lymphoid neoplasms, autoimmune disease and other conditions. Identified biomarkers can be used to determine and/or monitor the disease state for a subject with an associated lymphoid disorder or autoimmune disease or other condition. In particular, the invention provides a sensitive method for monitoring lymphoid neoplasms that undergo clonal evolutions without the need to development alternative assays for the evolved or mutated clones serving as patient-specific biomarkers.
    • 需要一种改进的方法来确定包括自身免疫性疾病和癌症在内的患者的诊断和预后,特别是淋巴瘤和白血病等淋巴样肿瘤。 本文提供了使用DNA测序鉴定患有淋巴样肿瘤,自身免疫疾病和其他病症的个体化或患者特异性生物标志物的方法。 识别的生物标志物可以用于确定和/或监测具有相关淋巴样病症或自身免疫疾病或其他病症的受试者的疾病状态。 特别地,本发明提供了用于监测经历克隆进化的淋巴样肿瘤的敏感方法,而不需要用作用作患者特异性生物标志物的进化或突变克隆的替代性测定。
    • 13. 发明授权
    • Sequence analysis of complex amplicons
    • 复合扩增子的序列分析
    • US08691510B2
    • 2014-04-08
    • US13100389
    • 2011-05-04
    • Malek FahamMartin MoorheadThomas Willis
    • Malek FahamMartin MoorheadThomas Willis
    • C12Q1/68C12P19/34
    • C12Q1/6881C12Q1/6874C12Q1/6883C12Q2600/158C12Q2600/16
    • The invention is directed to methods of generating sequence profiles of populations of nucleic acids, whose member nucleic acids contain regions of high variability, such as populations of nucleic acids encoding T cell receptors or B cell receptors. In one aspect, the invention provides pluralities of sets of primers for generating nested sets of templates from nucleic acids in such populations, thereby insuring the production of at least one template from which sequence reads are generated, despite such variability, or dispite limited lengths or quality of sequence reads. In another aspect, members of such populations are bidirectionally sequenced so that further sequence information is obtained by analyzing overlapping sequence reads in the zones of highest variability.
    • 本发明涉及产生核酸群体序列谱的方法,该核酸的成员核酸含有高度变异性的区域,例如编码T细胞受体或B细胞受体的核酸群体。 在一个方面,本发明提供了多组引物,用于从这些群体中的核酸产生嵌套的模板集合,从而确保产生序列读取的至少一个模板的产生,尽管存在这种变化,或者限制长度或 序列读取的质量。 在另一方面,这些群体的成员被双向排序,以便通过分析最高变异性区域中的重叠序列读数来获得进一步的序列信息。
    • 15. 发明申请
    • METHODS OF MONITORING CONDITIONS BY SEQUENCE ANALYSIS
    • 通过序列分析监测条件的方法
    • US20110207135A1
    • 2011-08-25
    • US13100389
    • 2011-05-04
    • Malek FahamMartin MoorheadThomas Willis
    • Malek FahamMartin MoorheadThomas Willis
    • C12Q1/68
    • C12Q1/6881C12Q1/6874C12Q1/6883C12Q2600/158C12Q2600/16
    • The invention is directed to methods of generating sequence profiles of populations of nucleic acids, whose member nucleic acids contain regions of high variability, such as populations of nucleic acids encoding T cell receptors or B cell receptors. In one aspect, the invention provides pluralities of sets of primers for generating nested sets of templates from nucleic acids in such populations, thereby insuring the production of at least one template from which sequence reads are generated, despite such variability, or dispite limited lenghs or quality of sequence reads. In another aspect, members of such populations are bidirectionally sequenced so that further sequence information is obtained by analyzing overlapping sequence reads in the zones of highest variability.
    • 本发明涉及产生核酸群体序列谱的方法,该核酸的成员核酸含有高度变异性的区域,例如编码T细胞受体或B细胞受体的核酸群体。 在一个方面,本发明提供了多组引物,用于从这些群体中的核酸产生嵌套的模板集合,从而确保产生序列读数的至少一个模板的产生,尽管存在这种可变性,或者排除有限的长度或 序列读取的质量。 在另一方面,这些群体的成员被双向排序,以便通过分析最高变异性区域中的重叠序列读数来获得进一步的序列信息。
    • 17. 发明申请
    • METHOD OF DETERMINING CLONOTYPES AND CLONOTYPE PROFILES
    • 确定克隆和克隆型材的方法
    • US20150167080A1
    • 2015-06-18
    • US13196885
    • 2011-08-02
    • Martin MoorheadMalek FahamThomas Willis
    • Martin MoorheadMalek FahamThomas Willis
    • C12Q1/68C40B20/00
    • C12Q1/6881C12Q1/6883C12Q2600/156C12Q2600/158C12Q2600/16G06F19/14G06F19/22
    • The invention is directed to methods for determining clonotypes and clonotype profiles in assays for analyzing immune repertoires by high throughput nucleic acid sequencing of somatically recombined immune molecules. In one aspect, the invention comprises generating a clonotype profile from an individual by generating sequence reads from a sample of recombined immune molecules; forming from the sequence reads a sequence tree representing candidate clonotypes each having a frequency; coalescing with a highest frequency candidate clonotype any lesser frequency candidate clonotypes whenever such lesser frequency is below a predetermined value and whenever a sequence difference therebetween is below a predetermined value to form a clonotype. After such coalescence, the candidate clonotypes is removed from the sequence tree and the process is repeated. This approach permits rapid and efficient differentiation of candidate clonotypes with genuine sequence differences from those with experimental or measurement errors, such as sequencing errors.
    • 本发明涉及用于通过体细胞重组的免疫分子的高通量核酸测序分析免疫谱的测定中的克隆型和克隆型谱的方法。 在一个方面,本发明包括通过从重组的免疫分子的样品产生序列读数来从个体产生克隆型谱; 从序列形成读取表示每个具有频率的候选克隆型的序列树; 每当这样较小的频率低于预定值,并且每当它们之间的序列差异低于预定值以形成克隆型时,以最高频率候选克隆型任何较低频率候选克隆型聚合。 在这样的聚结之后,从序列树中移除候选克隆型,并重复该过程。 这种方法允许用具有实验或测量误差(例如测序错误)的那些具有真正序列差异的候选克隆型的快速和有效的分化。
    • 18. 发明授权
    • Method of determining clonotypes and clonotype profiles
    • 确定克隆型和克隆型谱的方法
    • US09043160B1
    • 2015-05-26
    • US13196885
    • 2011-08-02
    • Martin MoorheadMalek FahamThomas Willis
    • Martin MoorheadMalek FahamThomas Willis
    • G06F7/00G06F19/14
    • C12Q1/6881C12Q1/6883C12Q2600/156C12Q2600/158C12Q2600/16G06F19/14G06F19/22
    • The invention is directed to methods for determining clonotypes and clonotype profiles in assays for analyzing immune repertoires by high throughput nucleic acid sequencing of somatically recombined immune molecules. In one aspect, the invention comprises generating a clonotype profile from an individual by generating sequence reads from a sample of recombined immune molecules; forming from the sequence reads a sequence tree representing candidate clonotypes each having a frequency; coalescing with a highest frequency candidate clonotype any lesser frequency candidate clonotypes whenever such lesser frequency is below a predetermined value and whenever a sequence difference therebetween is below a predetermined value to form a clonotype. After such coalescence, the candidate clonotypes is removed from the sequence tree and the process is repeated. This approach permits rapid and efficient differentiation of candidate clonotypes with genuine sequence differences from those with experimental or measurement errors, such as sequencing errors.
    • 本发明涉及用于通过体细胞重组的免疫分子的高通量核酸测序分析免疫谱的测定中的克隆型和克隆型谱的方法。 在一个方面,本发明包括通过从重组的免疫分子的样品产生序列读数来从个体产生克隆型谱; 从序列形成读取表示每个具有频率的候选克隆型的序列树; 每当这样较小的频率低于预定值,并且每当它们之间的序列差异低于预定值以形成克隆型时,以最高频率候选克隆型任何较低频率候选克隆型聚合。 在这样的聚结之后,从序列树中移除候选克隆型,并重复该过程。 这种方法允许用具有实验或测量误差(例如测序错误)的那些具有真正序列差异的候选克隆型的快速和有效的分化。